Novel protective effects of stem cell factor in a murine model of acute septic peritonitis: dependence on MCP-1

CL Bone-Larson, CM Hogaboam… - The American journal of …, 2000 - Elsevier
CL Bone-Larson, CM Hogaboam, ML Steinhauser, SHP Oliveira, NW Lukacs, RM Strieter
The American journal of pathology, 2000Elsevier
Mast cells participate in the host response during sepsis and have been shown to have a
protective effect in a murine model of acute septic peritonitis and multi-organ failure initiated
by cecal ligation and puncture (CLP). Stem cell factor (SCF) is a hematopoietic cytokine
important in mast cell proliferation and activation. In the present study, we examined the
protective effects of a single intraperitoneal injection of SCF given 2 hours before CLP
surgery in mice. Four days after the CLP surgery, SCF pretreatment significantly improved …
Mast cells participate in the host response during sepsis and have been shown to have a protective effect in a murine model of acute septic peritonitis and multi-organ failure initiated by cecal ligation and puncture (CLP). Stem cell factor (SCF) is a hematopoietic cytokine important in mast cell proliferation and activation. In the present study, we examined the protective effects of a single intraperitoneal injection of SCF given 2 hours before CLP surgery in mice. Four days after the CLP surgery, SCF pretreatment significantly improved mouse survival from 29 to 56% and mast cells were absolutely required for this effect. Immunoneutralization studies revealed that the SCF-stimulated release of monocyte chemoattractant protein-1 (MCP-1) into the septic peritoneal cavity contributed to the protective effect of SCF in this model. One potential cellular source of MCP-1 was the SCF-activated mast cell. In addition, SCF pretreatment significantly augmented circulating levels of SCF and the immunomodulatory cytokine interleukin-10 in septic mice, in part because the SCF pretreatment seemed to promote the release of both mediators from the liver. Additional hepatic effects of SCF treatment included an accelerated expression of hepatic levels of signal transducer and activator of transcription-3 (STAT-3) in CLP mice pretreated with SCF. Taken together, the findings from the present study demonstrate that the intraperitoneal delivery of SCF has a major protective effect in a murine model of CLP.
Elsevier